Tag: FB

  • Facebook Inc Valuation – January 2019 $FB

    Facebook Inc Valuation – January 2019 $FB

    Facebook, Inc. Common Stock is suitable for the Enterprising Investor but not the more conservative Defensive Investor. The Defensive Investor is concerned with the insufficient earnings stability over the last ten years, and the poor dividend history, and the high PEmg and PB ratios.

  • Facebook Inc Valuation – March 2018 $FB

    Facebook Inc Valuation – March 2018 $FB

    Facebook Inc is suitable for the Enterprising Investor but not the more conservative Defensive Investor. The Defensive Investor is concerned with the insufficient earnings stability over the last ten years, and the poor dividend history, and the high PEmg and PB ratios.

  • Facebook Inc Valuation – July 2016 $FB

    Facebook Inc Valuation – July 2016 $FB

    Facebook Inc is suitable for the Enterprising Investor but not the more conservative Defensive Investor. The Defensive Investor is concerned with the insufficient earnings stability over the last ten years, and the poor dividend history, and the high PEmg and PB ratios.

  • Facebook Inc Valuation – January 2016 Update $FB

    Facebook Inc Valuation – January 2016 Update $FB

    Facebook Inc qualifies for the Enterprising Investor but not the more conservative Defensive Investor. The Defensive Investor is concerned with the short history as a publicly traded company, the lack of dividends, and the high PEmg and PB ratios.

  • Facebook Inc. Analysis – August 2015 Update $FB

    Facebook Inc. Analysis – August 2015 Update $FB

    Facebook Inc. qualifies for the Enterprising Investor but not the more conservative Defensive Investor. The Defensive Investor is concerned with the short history as a publicly traded company, lack of dividends as well as the high PEmg and PB ratios.

  • Facebook Stock Analysis – Quarterly Update May 2015 $FB

    Facebook Stock Analysis – Quarterly Update May 2015 $FB

    As this Facebook stock analysis shows, Facebook Inc. is suitable for the Enterprising Investor but not for the Defensive Investor. The Defensive Investor is concerned by the short operating history as a publicly traded company, as well as the high PEmg and PB ratios, while the Enterprising Investor is only initially concerned by the lack of dividends.

  • 28 Companies in the Spotlight This Week – 2/28/15

    28 Companies in the Spotlight This Week – 2/28/15

    We evaluated 28 different companies this week to determine whether they are suitable for Defensive Investors, those unwilling to do substantial research, or Enterprising Investors, those who are willing to do such research. We also put each company through the ModernGraham valuation model based on Benjamin Graham’s value investing formulas in order to determine an intrinsic value for each. Here’s a summary of the ModernGraham Valuations.

  • Facebook Inc. Quarterly Valuation – February 2015 $FB

    Facebook Inc. Quarterly Valuation – February 2015 $FB

    Facebook is suitable for the Enterprising Investor, but not the more conservative Defensive Investor, who is concerned with the lack of dividends, short operating history as a publicly traded company, as well as the high PEmg and PB ratios.

  • 22 Companies in the Spotlight This Week – 11/29/14

    22 Companies in the Spotlight This Week – 11/29/14

    We evaluated 22 different companies this week to determine whether they are suitable for Defensive Investors, those unwilling to do substantial research, or Enterprising Investors, those who are willing to do such research. We also put each company through the ModernGraham valuation model based on Benjamin Graham’s value investing formulas in order to determine an intrinsic value for each. Here’s a summary of the ModernGraham Valuations.

  • Facebook Inc. Quarterly Valuation – November 2014 $FB

    Facebook Inc. Quarterly Valuation – November 2014 $FB

    Facebook is suitable for the Enterprising Investor, but not the Defensive Investor, who is concerned with the short earnings history, lack of dividend payments and the high PEmg and PB ratios.